December 28, 2022- December 31, 2022/ 8:30 am - 3:00 pm
Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges. Intellectual Property (IP) has been central to great scientific advances and for ensuring that patients have access to this innovation. IP helps foster long term investment to benefit patients – today and tomorrow.
Speakers
Jean-Christophe Tellier,
CEO, UCB & Chair of the Biopharmaceutical CEO Roundtable (BCR)
Paola Barbarino
CEO, Alzheimer’s Disease International
Sune Stampe Sørensen
Director General, Danish Patent and Trademark Office
Thomas Cueni
Director General, IFPMA